Phospholipase A2: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 58: | Line 58: | ||
Removing the labels, atropine can be seen making contact with the atoms emphasized by the space filling model, interacting with the <scene name='Sandbox_53/Phospholipase2a_interactions/1'>active site</scene> of phospholipase 2A through white as-tricks. | Removing the labels, atropine can be seen making contact with the atoms emphasized by the space filling model, interacting with the <scene name='Sandbox_53/Phospholipase2a_interactions/1'>active site</scene> of phospholipase 2A through white as-tricks. | ||
== 3D Structures of Phospholipase A2 == | |||
[[Phospholipase A2 3D structures]] | |||
</StructureSection> | </StructureSection> | ||
Line 67: | Line 71: | ||
*Phospholipase A2 | *Phospholipase A2 | ||
**[[1ayp]], [[1bbc]], [[1pod]] – hPLA2 – human<br /> | |||
**[[1rlw]] – hPLA2 CALB domain<br /> | |||
**[[1une]], [[1mkt]], [[1irb]], [[1bp2]], [[1bpq]], [[1g4i]], [[2bp2]], [[2bpp]] - bPLA2 – bovine<br /> | **[[1une]], [[1mkt]], [[1irb]], [[1bp2]], [[1bpq]], [[1g4i]], [[2bp2]], [[2bpp]] - bPLA2 – bovine<br /> | ||
**[[2zp3]], [[2zp4]], [[2zp5]], [[1c74]], [[1kvw]], [[1kvx]], [[1kvy]], [[1ceh]], [[1mks]], [[1mku]], [[1vkq]], [[1vl9]], [[2bax]], [[2bch]], [[2bd1]], [[1o3w]], [[1gh4]] – bPLA2 (mutant) | **[[2zp3]], [[2zp4]], [[2zp5]], [[1c74]], [[1kvw]], [[1kvx]], [[1kvy]], [[1ceh]], [[1mks]], [[1mku]], [[1vkq]], [[1vl9]], [[2bax]], [[2bch]], [[2bd1]], [[1o3w]], [[1gh4]] – bPLA2 (mutant) <br /> | ||
**[[1bvm]] – bPLA2 - NMR<br /> | **[[1bvm]] – bPLA2 - NMR<br /> | ||
**[[1p2p]], [[4p2p]] – pPLA2 - pig<br /> | |||
**[[1y6p]], [[2phi]], [[3p2p]] – pPLA2 (mutant) – pig<br /> | |||
**[[1sfv]], [[1sfw]], [[1pir]], [[1pis]] – pPLA2 - NMR<br /> | |||
**[[1qll]], [[2q2j]] – PLA2 – ''Bothrops pirajai''<br /> | **[[1qll]], [[2q2j]] – PLA2 – ''Bothrops pirajai''<br /> | ||
**[[2qog]] – PLA2 – ''Crotalus durissus''<br /> | **[[2qog]] – PLA2 – ''Crotalus durissus''<br /> | ||
Line 77: | Line 86: | ||
**[[2osn]], [[1fe5]], [[1dpy]] – kPLA2 – krait<br /> | **[[2osn]], [[1fe5]], [[1dpy]] – kPLA2 – krait<br /> | ||
**[[1g0z]], [[1g2x]] – kPLA2 (mutant)<br /> | **[[1g0z]], [[1g2x]] – kPLA2 (mutant)<br /> | ||
**[[1yxh]] – NsPLA2 – ''Naja sagittifera''<br /> | **[[1yxh]] – NsPLA2 – ''Naja sagittifera''<br /> | ||
**[[1oz6]], [[2qhe]] – PLA2 – ''Echis carinatus''<br /> | **[[1oz6]], [[2qhe]] – PLA2 – ''Echis carinatus''<br /> | ||
**[[1mg6]] – PLA2 – ''Agkistrodon acutus''<br /> | **[[1mg6]] – PLA2 – ''Agkistrodon acutus''<br /> | ||
**[[1s8g]], [[1s8h]], [[1s8i]] – PLA2 – copperhead<br /> | **[[1s8g]], [[1s8h]], [[1s8i]] – PLA2 – copperhead<br /> | ||
Line 97: | Line 101: | ||
**[[1aok]], [[1jlt]], [[1q5t]], [[1rgb]], [[3dih]], [[3g8g]], [[3g8h]] – PLA2 – ''Vipera ammodytes''<br /> | **[[1aok]], [[1jlt]], [[1q5t]], [[1rgb]], [[3dih]], [[3g8g]], [[3g8h]] – PLA2 – ''Vipera ammodytes''<br /> | ||
**[[2i0u]] – PLA2 – ''Vipera nikolskii''<br /> | **[[2i0u]] – PLA2 – ''Vipera nikolskii''<br /> | ||
**[[1god]] – PLA2 – ''Cerrophidion godmani''<br /> | **[[1god]] – PLA2 – ''Cerrophidion godmani''<br /> | ||
**[[1gp7]], [[1m8t]] – PLA2 – ''Ophiophagus hanna''<br /> | **[[1gp7]], [[1m8t]] – PLA2 – ''Ophiophagus hanna''<br /> | ||
Line 108: | Line 109: | ||
**[[2aoz]] – PLA2 – ''Atropoides nummifer''<br /> | **[[2aoz]] – PLA2 – ''Atropoides nummifer''<br /> | ||
**[[3v9m]] – PLA2 – king brown snake<br /> | **[[3v9m]] – PLA2 – king brown snake<br /> | ||
**[[2wg7]], [[2wg8]] – rPLA2 – rice<br /> | |||
**[[1faz]], [[1kp4]] – SvPLA2 – ''Streptomyces violaceruber''<br /> | |||
**[[1it4]], [[1it5]] – SvPLA2 – NMR<br /> | |||
*Phospholipase A2 group I | *Phospholipase A2 group I | ||
**[[3elo]] – hPLA2G1B<br /> | **[[3elo]] – hPLA2G1B<br /> | ||
**[[3fvi]], [[3fvj]] – pPLA2G1B+octyl sulfate<br /> | **[[3fvi]], [[3fvj]] – pPLA2G1B+octyl sulfate<br /> | ||
**[[3qlm]] - pPLA2G1B + hexadecanoic acid<br /> | **[[3qlm]] - pPLA2G1B + hexadecanoic acid<br /> | ||
Line 118: | Line 121: | ||
**[[4g5i]] – pPLA2 + DBP<br /> | **[[4g5i]] – pPLA2 + DBP<br /> | ||
**[[4o1y]] – pPLA2 + naphthalene acetic acid<br /> | **[[4o1y]] – pPLA2 + naphthalene acetic acid<br /> | ||
**[[3q4y]] - PLA2G1 - Andaman cobra <br /> | |||
**[[3osh]] – NnPLA2G1+atropine | **[[3osh]] – NnPLA2G1+atropine | ||
Line 124: | Line 128: | ||
**[[1j1a]], [[3u8b]] – hPLA2G2A<br /> | **[[1j1a]], [[3u8b]] – hPLA2G2A<br /> | ||
**[[1n28]], [[1n29]] – hPLA2G2A (mutant)<br /> | **[[1n28]], [[1n29]] – hPLA2G2A (mutant)<br /> | ||
**[[1kqu]], [[1kvo]] – hPLA2G2A+substrate analog<br /> | **[[1kqu]], [[1kvo]] – hPLA2G2A+substrate analog<br /> | ||
**[[3u8d]], [[3u8h]], [[3u8i]], [[4hmb]] - hPLA2G2A + inhibitor<br /> | **[[3u8d]], [[3u8h]], [[3u8i]], [[4hmb]] - hPLA2G2A + inhibitor<br /> | ||
Line 132: | Line 133: | ||
**[[5wzw]], [[5wzv]], [[5wzu]], [[5wzt]], [[5wzs]], [[5wzo]], [[5wzm]] - hPLA2G2E + inhibitor<br /> | **[[5wzw]], [[5wzv]], [[5wzu]], [[5wzt]], [[5wzs]], [[5wzo]], [[5wzm]] - hPLA2G2E + inhibitor<br /> | ||
**[[5yse]] - hPLA2G2E (mutant) + inhibitor<br /> | **[[5yse]] - hPLA2G2E (mutant) + inhibitor<br /> | ||
**[[3mlm]] – PLA2G2 + myristic acid – ''Neuwiedi lancehead''<br /> | |||
**[[1cl5]], [[1fb2]], [[1vip]], [[2pvt]], [[2pyc]], [[5vet]] – DrPLA2 – ''Daboia russellii''<br /> | |||
**[[2qhw]] – DrPLA2 + gramine derivative<br /> | |||
**[[2que]] – DrPLA2 + ajamaline + anisic acid<br /> | |||
**[[4fga]], [[4gfy]], [[4gld]] – DrPLA2 + polypeptide<br /> | |||
**[[3g8f]] – DrPLA2G2+polypeptide<br /> | **[[3g8f]] – DrPLA2G2+polypeptide<br /> | ||
*Human PLA2 group IVd | *Human PLA2 group IVd | ||
Line 167: | Line 171: | ||
*Phospholipase A2 +inhibitor | *Phospholipase A2 +inhibitor | ||
**[[3o4m]], [[3hsw]] – | **[[1db4]], [[1db5]], [[1dcy]] – hPLA2+indole<br /> | ||
**[[1poe]] – hPLA2+phosphonyl inhibitor<br /> | |||
**[[1fdk]] – bPLA2+MJ33<br /> | |||
**[[1mkv]] – bPLA2+transition state analog<br /> | |||
**[[1o2e]] – bPLA2 (mutant)+anisic acid<br /> | |||
**[[2b96]] - bPLA2+benzoic acid derivative<br /> | |||
**[[3bp2]] – bPLA2+pyruvic acid<br /> | |||
**[[3o4m]], [[3hsw]] – pPLA2+inhibitor <br /> | |||
**[[2azy]], [[2azz]], [[2b00]], [[2b01]], [[2b03]], [[2b04]] – pPLA2+cholate derivative<br /> | **[[2azy]], [[2azz]], [[2b00]], [[2b01]], [[2b03]], [[2b04]] – pPLA2+cholate derivative<br /> | ||
**[[1y6o]], [[1fx9]], [[1fxf]] – pPLA2+MJ33<br /> | **[[1y6o]], [[1fx9]], [[1fxf]] – pPLA2+MJ33<br /> | ||
Line 187: | Line 198: | ||
**[[1oxr]] – NsPLA2+aspirin<br /> | **[[1oxr]] – NsPLA2+aspirin<br /> | ||
**[[1bk9]] – AhPLA2+PBPB<br /> | **[[1bk9]] – AhPLA2+PBPB<br /> | ||
**[[1pob]] - NnPLA2+transition state analog<br /> | **[[1pob]] - NnPLA2+transition state analog<br /> | ||
**[[1poc]] - PLA2+transition state analog – Honey bee<br /> | **[[1poc]] - PLA2+transition state analog – Honey bee<br /> | ||
**[[1fv0]] – DrPLA2+aristolochic acid<br /> | **[[1fv0]] – DrPLA2+aristolochic acid<br /> | ||
**[[1sv3]] - DrPLA2+benzoic acid derivative<br /> | **[[1sv3]] - DrPLA2+benzoic acid derivative<br /> | ||
Line 233: | Line 237: | ||
*Lp-PLA2 | *Lp-PLA2 | ||
**[[3d59]] – hLP-PLA2 residues 47-429 <br /> | |||
**[[1wab]] – bLP-PLA2 + acetate <br /> | **[[1wab]] – bLP-PLA2 + acetate <br /> | ||
**[[1bwp]], 1bwq]], 1bwr]], 1es9]] – bLP-PLA2 ( mutant) <br /> | **[[1bwp]], 1bwq]], 1bwr]], 1es9]] – bLP-PLA2 ( mutant) <br /> | ||
Line 238: | Line 243: | ||
**[[1uuj]] - mLP-PLA2 α subunit N terminal – mouse<br /> | **[[1uuj]] - mLP-PLA2 α subunit N terminal – mouse<br /> | ||
**[[1vyh]] - mLP-PLA2 α subunit C terminal + β subunit<br /> | **[[1vyh]] - mLP-PLA2 α subunit C terminal + β subunit<br /> | ||
*Lp-PLA2 binary complexes | *Lp-PLA2 binary complexes | ||
**[[3dt9]] - bLP-PLA2 α subunit (mutant) + soman<br /> | **[[3dt9]] - bLP-PLA2 α subunit (mutant) + soman<br /> | ||
**[[3d5e]] - hLP-PLA2 residues 47-429 + paraoxon<br /> | **[[3d5e]] - hLP-PLA2 residues 47-429 + paraoxon<br /> | ||
Line 252: | Line 254: | ||
**[[5i8p]], [[5i9i]], [[5jad]], [[5jah]], [[5jal]], [[5jan]], [[5jao]], [[5jap]], [[5jar]], [[5jas]], [[5jat]], [[5jau]], [[5lp1]], [[5lz2]], [[5lz8]], [[5lz9]] - hLP-PLA2 residues 47-429 + inhibitor<br /> | **[[5i8p]], [[5i9i]], [[5jad]], [[5jah]], [[5jal]], [[5jan]], [[5jao]], [[5jap]], [[5jar]], [[5jas]], [[5jat]], [[5jau]], [[5lp1]], [[5lz2]], [[5lz8]], [[5lz9]] - hLP-PLA2 residues 47-429 + inhibitor<br /> | ||
**[[5lyy]], [[5lz4]], [[5lz5]], [[5lz7]] - hLP-PLA2 residues 47-429 (mutant) + inhibitor<br /> | **[[5lyy]], [[5lz4]], [[5lz5]], [[5lz7]] - hLP-PLA2 residues 47-429 (mutant) + inhibitor<br /> | ||
**[[3dt6]] - bLP-PLA2 α subunit (mutant) + paraoxon<br /> | |||
**[[3dt8]] - bLP-PLA2 α subunit (mutant) + sarin<br /> | |||
**[[3dt9]] - bLP-PLA2 α subunit (mutant) + soman<br /> | |||
*Bothrops toxins | *Bothrops toxins | ||
Line 275: | Line 280: | ||
*Pro-Phospholipase A2 | *Pro-Phospholipase A2 | ||
**[[4bp2]] – bPPLA2<br /> | |||
**[[1hn4]] – pPPLA2+MJ33<br /> | **[[1hn4]] – pPPLA2+MJ33<br /> | ||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |